HCA Healthcare (HCA) UBS Global Healthcare Conference summary

Performance highlights and challenges

• Adjusted admissions volume grew about 5%, exceeding expectations due to strong market demographics, execution, and coverage environment.

• Physician costs moderated throughout the year, improving each quarter.

• Hurricanes caused a $50M impact in Q3 and $200–$300M in Q4, with ongoing effects in North Carolina and a Tampa facility reopening by year-end.

• Two-Midnight Rule contributed about 0.5% to admissions growth, with minimal further impact expected in 2025.

• Labor costs stabilized, with wage increases of 2.5–3.5% and contract labor at 4.5% of SW&B.

Forward outlook and strategic priorities

• Volume growth for 2025 is projected at 3–4%, above historical averages, supported by exchange and Medicare trends.

• Advocacy efforts are underway to address potential loss of enhanced exchange subsidies after 2025.

• Capital spending remains robust, with $5B planned for 2024 and a $6B pipeline, focusing on both inpatient and outpatient expansion.

• Market share targeted to increase from 27% by end of decade through network expansion and operational efficiency.

• Managed care contracting remains strong, with 80% of 2025 contracts secured at favorable rates.

Regulatory, payer, and market dynamics

• Exchange admissions represent 7% of total, contributing 8–9% of revenue, with rates second only to commercial payers.

• Supplemental Medicaid payments have grown, improving coverage but still not fully covering costs; regulatory changes may provide further headroom.

• Tariff risks are mitigated by contracts through 2025, with flexibility to adjust sourcing if needed.

• Denials and claims review remain a focus, especially under the Two-Midnight Rule, with ongoing payer negotiations.

• No significant shift toward joint ventures in specialty service lines; partnerships exist but are not a major strategy.